163 related articles for article (PubMed ID: 22623561)
1. Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose IV gemcitabine.
Tanaka T; Sho M; Nishiofuku H; Sakaguchi H; Inaba Y; Nakajima Y; Kichikawa K
AJR Am J Roentgenol; 2012 Jun; 198(6):1445-52. PubMed ID: 22623561
[TBL] [Abstract][Full Text] [Related]
2. 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer.
Takamori H; Kanemitsu K; Tsuji T; Tanaka H; Chikamoto A; Nakahara O; Hiraoka T; Ikeda O; Kudo K; Imuta M; Yamashita Y
Pancreas; 2005 Apr; 30(3):223-6. PubMed ID: 15782098
[TBL] [Abstract][Full Text] [Related]
3. A Phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable advanced pancreatic cancer after vascular supply distribution via superselective embolization.
Miyanishi K; Ishiwatari H; Hayashi T; Takahashi M; Kawano Y; Takada K; Ihara H; Okuda T; Takanashi K; Takahashi S; Sato Y; Matsunaga T; Homma H; Kato J; Niitsu Y
Jpn J Clin Oncol; 2008 Apr; 38(4):268-74. PubMed ID: 18375446
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer.
Zanon C; Alabiso O; Grosso M; Buosi R; Chiappino I; Clara R; Satolli A; Zai S; Bortolini M; Botta M; Mussa A
Int J Pancreatol; 2000 Jun; 27(3):225-33. PubMed ID: 10952405
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of combined continuous arterial infusion and systemic chemotherapy for the treatment of advanced pancreatic carcinoma.
Ikeda O; Kusunoki S; Kudoh K; Takamori H; Tsuji T; Kanemitsu K; Yamashita Y
Cardiovasc Intervent Radiol; 2006; 29(3):362-70. PubMed ID: 16502181
[TBL] [Abstract][Full Text] [Related]
6. Arterial infusion of 5-fluorouracil combined with concurrent radiotherapy for unresectable pancreatic cancer: results from a pilot study.
Tanaka T; Sakaguchi H; Anai H; Yamamoto K; Morimoto K; Tamamoto T; Kichikawa K
AJR Am J Roentgenol; 2007 Aug; 189(2):421-8. PubMed ID: 17646470
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial chemoinfusion prior to chemoradiotherapy with full-dose systemic gemcitabine for management of locally advanced pancreatic cancer.
Tanaka T; Nishiofuku H; Tamamoto T; Sho M; Anai H; Sueyoshi S; Sakaguchi H; Hasegawa M; Nakajima Y; Kichikawa K
Anticancer Res; 2011 Nov; 31(11):3909-12. PubMed ID: 22110218
[TBL] [Abstract][Full Text] [Related]
8. Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study.
Beane JD; Griffin KF; Levy EB; Pandalai P; Wood B; Abi-Jaoudeh N; Beresnev T; Shutack Y; Webb CC; Avital I; Rudloff U
Invest New Drugs; 2015 Feb; 33(1):109-18. PubMed ID: 25236592
[TBL] [Abstract][Full Text] [Related]
9. Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I-II study.
Barone C; Cassano A; Corsi DC; Pozzo C; Longo R; Schinzari G; Quirino M; Battelli C; Basso M
Oncology; 2003; 64(2):139-45. PubMed ID: 12566911
[TBL] [Abstract][Full Text] [Related]
10. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.
Berlin JD; Catalano P; Thomas JP; Kugler JW; Haller DG; Benson AB
J Clin Oncol; 2002 Aug; 20(15):3270-5. PubMed ID: 12149301
[TBL] [Abstract][Full Text] [Related]
11. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
[TBL] [Abstract][Full Text] [Related]
12. A novel interventional radiology technique for arterial infusion chemotherapy against advanced pancreatic cancer.
Tanaka T; Sakaguchi H; Sho M; Yamamoto K; Nishiofuku H; Nakajima Y; Kichikawa K
AJR Am J Roentgenol; 2009 Apr; 192(4):W168-77. PubMed ID: 19304677
[TBL] [Abstract][Full Text] [Related]
13. Continuous transarterial infusion chemotherapy with gemcitabine and 5-Fluorouracil for advanced pancreatic carcinoma.
Hong GB; Zhou JX; Sun HB; Li CY; Song LQ
Asian Pac J Cancer Prev; 2012; 13(6):2669-73. PubMed ID: 22938439
[TBL] [Abstract][Full Text] [Related]
14. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
[TBL] [Abstract][Full Text] [Related]
15. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
Hidalgo M; Castellano D; Paz-Ares L; Gravalos C; Diaz-Puente M; Hitt R; Alonso S; Cortes-Funes H
J Clin Oncol; 1999 Feb; 17(2):585-92. PubMed ID: 10080603
[TBL] [Abstract][Full Text] [Related]
16. Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
Park SJ; Kim H; Shin K; Hong TH; Suh JH; Lee MA
BMC Cancer; 2021 Nov; 21(1):1176. PubMed ID: 34732161
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer.
Ch'ang HJ; Wang CC; Cheng AL; Hsu C; Lu YS; Chang MC; Lin JT; Wang HP; Shiah HS; Liu TW; Chang JY; Whang-Peng J; Chen LT
J Gastroenterol Hepatol; 2006 May; 21(5):874-9. PubMed ID: 16704539
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer.
Huang J; Robertson JM; Margolis J; Balaraman S; Gustafson G; Khilanani P; Nadeau L; Jury R; McIntosh B
Radiother Oncol; 2011 May; 99(2):114-9. PubMed ID: 21621866
[TBL] [Abstract][Full Text] [Related]
19. Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy.
Vogl TJ; Schwarz W; Eichler K; Hochmuth K; Hammerstingl R; Jacob U; Scheller A; Zangos S; Heller M
J Cancer Res Clin Oncol; 2006 Nov; 132(11):745-55. PubMed ID: 16858591
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.
Rakhra S; Strauss JB; Robertson J; McGinn CJ; Kim T; Huang J; Blake A; Helenowski I; Hayes JP; Mulcahy M; Small W
J Gastrointest Cancer; 2016 Jun; 47(2):196-201. PubMed ID: 27112332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
